A Safety Review and Meta-Analyses of Bevacizumab and Ranibizumab: Off-Label versus Goldstandard
Table 5
Rates of ocular adverse effects of RCTs evaluating ranibizumab for indirect comparison and dose-relationship evaluation.
Click through the PLOS taxonomy to find articles in your field.
For more information about PLOS Subject Areas, click here.
Rates of ocular adverse effects of RCTs evaluating ranibizumab for indirect comparison and dose-relationship evaluation.